Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT01803854 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Gulf War Era Cohort and Biorepository

Study acronym: CSP# 585
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Completion pushed from Jul 20, 2026 to Jul 20, 2027 Publications: details revised at 9 of 9 entries · Eligibility criteria expanded, about 3 words · Study description expanded, about 2 words Show 3 more changesShow less
    • Publications: details revised at 9 of 9 entries
    • Eligibility criteria expanded, about 3 words
    • Study description expanded, about 2 words
  2. Minor Re-verified, no change to tracked fieldsv36
  3. Minor Completion date: Jul 25, 2025 to Jul 20, 2026 Study description expanded, about 8 words · Publications expanded, about 397 wordsv35 Show 2 more changesShow less
    • Study description expanded, about 8 words
    • Publications expanded, about 397 words

    See this version in full on ClinicalTrials.gov ↗

  4. Minor Completion date: Jul 21, 2024 to Jul 25, 2025 Publications shortened, about 269 wordsv34 Show 1 more changeShow less
    • Publications shortened, about 269 words

    See this version in full on ClinicalTrials.gov ↗

  5. Minor Completion date: Jul 21, 2023 to Jul 21, 2024 Site details revisedv33 Show 1 more changeShow less
    • Site details revised
Show 31 earlier versionsHide 31 earlier versions
  1. Minor Publications: 3 to 6 Study description shortened, about 3 wordsv32 Show 1 more changeShow less
    • Study description shortened, about 3 words

    See this version in full on ClinicalTrials.gov ↗

  2. Notable Results first posted: Dec 2, 2021 Primary endpoints: 1 to 2 · Completion date: Jul 21, 2021 to Jul 21, 2023 · Study description expanded, about 6 words · 1 morev31 Show 4 more changesShow less
    • Primary endpoints: 1 to 2
    • Completion date: Jul 21, 2021 to Jul 21, 2023
    • Study description expanded, about 6 words
    • Publications: 2 to 3

    See this version in full on ClinicalTrials.gov ↗

  3. Minor Study description revised Publications: 1 to 2v30 Show 1 more changeShow less
  4. Minor Re-verified, no change to tracked fieldsv29
  5. Minor Publications: 2 to 1v28 See this version in full on ClinicalTrials.gov ↗
  6. Minor Completion date: Jul 21, 2019 to Jul 21, 2021 Study description revised · Publications expanded, about 96 wordsv27 Show 2 more changesShow less
    • Study description revised
    • Publications expanded, about 96 words

    See this version in full on ClinicalTrials.gov ↗

  7. Notable Primary and study completion dates: Sep 30, 2018 to Jul 21, 2019v26
  8. Minor Enrollment target: 1276 to 1275v25
  9. Minor Study description shortened, about 4 wordsv24 See this version in full on ClinicalTrials.gov ↗
  10. Minor Primary and study completion dates: Sep 2018 to Sep 30, 2018 Study description shortened, about 1 wordv23 Show 1 more changeShow less
    • Study description shortened, about 1 word

    See this version in full on ClinicalTrials.gov ↗

  11. Minor Start date: Sep 2014 to Sep 2, 2014 Study description shortened, about 5 wordsv22 Show 1 more changeShow less
    • Study description shortened, about 5 words

    See this version in full on ClinicalTrials.gov ↗

  12. Minor Enrollment target: estimated 5000 to confirmed 1276v21
  13. Minor Study description shortened, about 84 wordsv20 See this version in full on ClinicalTrials.gov ↗
  14. Minor Trial status: Recruiting to Active, Not Recruiting Site details revisedv19 Show 1 more changeShow less
    • Site details revised
  15. Notable Lead sponsor: US Department of Veterans Affairs to VA Office of Research and Development Enrollment target: 3000 to 5000 · Primary completion date: Jul 2016 to Sep 2018 · Completion date: Aug 2016 to Sep 2018 · 1 morev18 Show 4 more changesShow less
    • Enrollment target: 3000 to 5000
    • Primary completion date: Jul 2016 to Sep 2018
    • Completion date: Aug 2016 to Sep 2018
    • Study description expanded, about 2 words

    See this version in full on ClinicalTrials.gov ↗

  16. Minor Start date: Aug 2014 to Sep 2014v17
  17. Notable Primary completion date: Oct 2015 to Jul 2016 Study site revisedv16 Show 1 more changeShow less
  18. Minor 2 versions Re-verified since Jan 5, 2015, no change to tracked fieldsv14-v15
  19. Notable Trial status: Not Yet Recruiting to Recruiting Site details revisedv13 Show 1 more changeShow less
    • Site details revised
  20. Notable Primary completion date: Oct 2014 to Oct 2015 Start date: May 2014 to Aug 2014 · Completion date: Oct 2015 to Aug 2016 · Study description shortened, about 107 wordsv12 Show 3 more changesShow less
    • Start date: May 2014 to Aug 2014
    • Completion date: Oct 2015 to Aug 2016
    • Study description shortened, about 107 words

    See this version in full on ClinicalTrials.gov ↗

  21. Notable Start date: Aug 2013 to May 2014 Study description shortened, about 1 wordv11 Show 1 more changeShow less
    • Study description shortened, about 1 word

    See this version in full on ClinicalTrials.gov ↗

  22. Minor Eligibility criteria revisedv10 See this version in full on ClinicalTrials.gov ↗
  23. Minor Site contact updatedv9
  24. Minor Re-verified, no change to tracked fieldsv8
  25. Minor Site contact updatedv7
  26. Minor Primary completion date: Sep 2014 to Oct 2014 Completion date: Sep 2015 to Oct 2015 · Start date: Jul 2013 to Aug 2013 · Site contact updatedv6 Show 3 more changesShow less
    • Completion date: Sep 2015 to Oct 2015
    • Start date: Jul 2013 to Aug 2013
    • Site contact updated
  27. Minor Study site revisedv5 See this version in full on ClinicalTrials.gov ↗
  28. Notable Enrollment target: 10000 to 3000 Primary completion date: Jul 2014 to Sep 2014 · Completion date: Jul 2015 to Sep 2015 · Eligibility criteria shortened, about 19 words · 1 morev4 Show 4 more changesShow less
    • Primary completion date: Jul 2014 to Sep 2014
    • Completion date: Jul 2015 to Sep 2015
    • Eligibility criteria shortened, about 19 words
    • Study description expanded, about 10 words

    See this version in full on ClinicalTrials.gov ↗

  29. Notable Enrollment target: 3000 to 10000 Completion date: Jul 2017 to Jul 2015 · Study description revisedv3 Show 2 more changesShow less
    • Completion date: Jul 2017 to Jul 2015
    • Study description revised

    See this version in full on ClinicalTrials.gov ↗

  30. Notable Enrollment target: 30000 to 3000 Eligibility criteria shortened, about 6 words · Study description shortened, about 4 wordsv2 Show 2 more changesShow less
    • Eligibility criteria shortened, about 6 words
    • Study description shortened, about 4 words

    See this version in full on ClinicalTrials.gov ↗

  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The Gulf War Era Cohort and Biorepository pilot project collected epidemiological, survey, clinical, and environmental exposure data from Veterans who served during the 1990-1991 Gulf War Era. Approved researchers will be able to use these data and the blood samples to do future research about the health of Gulf War Era Veterans. During the pilot, the recruitment response rate and processes were assessed. The results revealed several opportunities for improvement. For this reason, CSP 585 research activities transitioned to a qualitative phase to focus more on the Veteran voice. In this stage, research staff spoke with Gulf War Era Veterans through focus groups, interviews, and other activities such as events and meetings to learn more about Veterans' experiences and/or ideas on this and other Gulf War research projects. This phase provided new information that can help researchers create better recruitment processes for future projects involving Gulf War Era Veterans. For more information on CSP 585, please contact Asia Johnson at asia.johnson4@va.gov and Christina Williams at christina.williams4@va.gov
Trial Details
NCT Number NCT01803854
Lead Sponsor VA Office of Research and Development
Conditions Gulf War Era Cohort
Enrollment 1,275 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov